logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

5 Micro and Small-Cap Biotechs Developing Stem Cell Treatments

By  +Follow August 1, 2013 8:43AM
Share:
Tickers Mentioned:

Stem cells have once again flitted through the news cycle, this time as a result of a new and growing industry that has arisen around the use of adult stem cells in cosmetic treatments that purport to both be more effective and less dangerous than traditional procedures such as the infamous and potentially toxic Botox injections.

But the scientific basis for the use of stem cells for cosmetic procedures is entirely tentative. To date, the US Food and Drug Administration has not approved any stem cell-based products for use, aside from a small number of umbilical cord blood-derived treatments for blood cancer as well as hereditary metabolic and autoimmune disorders.

Cosmetic treatments of any variety are subject to far less scrutiny than medical treatments, however, and this is what is currently allowing an increasing amount of doctors throughout the country to charge as much as $30,000 for procedures whose value are more or less unproven from the standpoint of official studies, clinical trials, and peer reviews.

Considering that so few medical products involving stem cells have been approved, a high degree of skepticism should probably be applied to any magical claims about the potential for stem cells to make one look younger, or to otherwise repair one’s perceived cosmetic iniquities. A terrifying article that appeared last December in The Scientific American suffices to support this contention.

But stem cells, whether of the adult of cord-blood variety, are believed to have regenerative properties that could repair all manner of human diseases and conditions, from cardiovascular conditions, to autoimmune diseases. The following five companies are biotechs that are working to ostensibly better the human condition through the use of stem-cell technology, and are all in the midst of clinical trials for various treatments, or on their way to beginning them

Osiris Therapeutics (OSIR) — With a market cap of $377 million, the Columbia, Maryland-based Osiris Therapeutics focuses on the development and marketing of stem cell products to treat serious inflammatory, autoimmune, orthopedic, and cardiovascular conditions. The company’s shares are currently priced at $11.45 and are up over 38 percent over the last six months.

Pluristem (PSTI) — The Israel-based Pluristem develops stem cell therapies from placenta cells for a number of diseases, and is currently preparing for clinical trials for a Peripheral Artery Disease treatment. The company has a market cap of $173.9 million, with shares trading at $2.98, down 7 percent over the past half year.

Cytori Therapeutics (CYTX) — Cytoris Therapeutics uses adult stem cells to develop regenerative therapies for cardiovascular conditions and soft tissue defects. The US company has a market cap of $188.9 million with shares currently priced at $2.82, up 2.5 percent over the last six months.

Neostem (NBS) — The New York, NY-based Neostem owns and operates a number of subsidiaries in the stem-cell based regenerative medicine industry that develop treatments for cardiovascular, autoimmune, and inflammatory conditions. The company is nearing clinical trials for a periodontitis treatment. With a market cap of $117.7 million, shares are currently priced at $7.05, up 10 percent over the past six months, and 17 percent year-to-date.

Advanced Cell Technology ($ACTC) — The Santa Monica, CA-based Advanced Cell Technology uses both adult and embryonic stem cells to develop treatments for retinal, blood, and heart diseases, and has recently initiated two different clinical trials for degenerative retinal disease. With a market cap of $179 million, shares are currently priced at $0.07, down $0.01 over the past six months.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for cytx
Trader News Daily
28 Feb 15 17:37:47
Wow http://t.co/PeRPkYu8Uk just posted last weeks results. +429%. Crazy. They offer a free trial too. $SFY $GST $HOV $JRJC $ISCO $CYTX
IH News Desk
28 Feb 15 17:31:05
$FB Opinions Updated Saturday, February 28, 2015 8:11:12 PM $OPXS $GG $ARIA $CYTX http://t.co/uG2e4plvyX
Quiver Full ™
28 Feb 15 17:03:59
@ChartReaderE This is exactly what I like to see 👏👏👏 $9!!! $CYTX This is a #Robust #Biotech with massive potential
Quiver Full ™
28 Feb 15 17:01:18
RT @Wolfofnasdaq: $CYTX BTW... This U.S. Drug therapy for Scleroderma is protected from Generic copycat for 10 years...
Quiver Full ™
28 Feb 15 17:00:50
RT @greenpennydiva: Quiver-Full: $CYTX FDA approval for significant trials last week The http://t.co/LaRKx3ZEvx
Quiver Full ™
28 Feb 15 17:00:43
RT @ChartReaderE: $CYTX #CHART.my_theory_? http://t.co/hx1NZV3gUv https://t.co/m73dSoTaEA http://t.co/XT9CWfcsMK
Investors Hangout
28 Feb 15 16:32:16
$CYTX News Updated Saturday, February 28, 2015 7:27:49 PM $EPGL $HEME $LXRP $MRNJ http://t.co/t1hp7YkBV8
Investors Hangout
28 Feb 15 16:32:14
$NOW Stock Message Board Updated Saturday, February 28, 2015 7:27:49 PM $BMSN $ONE $BID $CYTX http://t.co/zfaQ9WxpCm
Investors Hangout
28 Feb 15 16:32:13
$CRRS News Updated Saturday, February 28, 2015 7:27:49 PM $CYTX $ONE $CYTX $ANY http://t.co/EQ4PPiVPLT
Investors Hangout
28 Feb 15 16:32:12
$NEWL Filings Updated Saturday, February 28, 2015 7:26:19 PM $TIME $BAA $BID $CYTX http://t.co/yLgwZSe7nW
Investors Hangout
28 Feb 15 16:32:08
$DEWM Filings Updated Saturday, February 28, 2015 7:26:19 PM $MHYS $SNET $CYTX $VIZC http://t.co/1NCYgXyFEp
Fantastic
28 Feb 15 16:23:45
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Thomas F. McArthur
28 Feb 15 16:23:33
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
blackyannyann
28 Feb 15 16:23:11
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
robfarwaz
28 Feb 15 16:21:46
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Wini powo
28 Feb 15 16:21:00
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Pamila Geuder
28 Feb 15 16:20:00
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Zion Tribe Machine
28 Feb 15 16:19:28
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Cherri Angulo
28 Feb 15 16:19:20
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Aurelian Sandulescu
28 Feb 15 16:18:52
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
#81andSunny
28 Feb 15 16:18:33
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Lucas Santos
28 Feb 15 16:18:12
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Cherrie Chimes
28 Feb 15 16:16:27
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
RedBLB
28 Feb 15 16:15:21
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
maniek nowak
28 Feb 15 16:14:50
RT @hasnaebtaleb: Cheapies $CYCC and $CYTX closing strong.. $INVT $CAPNW for coming sessions.. Also @DekmarAlerts $LBIO making nHOD! Anothe…
Johnny Ca$h
28 Feb 15 16:07:34
RT @stockstobuy: Aoxing Pharma $AXN is the Top Penny Stock in 2015, Up 244% - http://t.co/czAZma7k1S #PennyStocks $SPRO $MTL $CYTX $CYCC $C…
Michael Della-Bosca
28 Feb 15 16:01:59
Looking for shorts on $cytx. break below the low of 1.05 will expose 0.80 and 0.70 in extension @KourtlandK http://t.co/gpqeu7T1c5
ChartReaderE
28 Feb 15 15:35:30
$CYTX #CHART.my_theory_? http://t.co/hx1NZV3gUv https://t.co/m73dSoTaEA http://t.co/XT9CWfcsMK
greenpennydiva
28 Feb 15 15:08:34
Quiver-Full: $CYTX FDA approval for significant trials last week The http://t.co/LaRKx3ZEvx
Joshua Soundararajan
28 Feb 15 15:00:18
RT @OzarkTrades: Watchlist for Mon 3/2 $GENE $CYTX $CAPN $CYCC $EYES
will crowder
28 Feb 15 14:30:32
RT @OzarkTrades: Watchlist for Mon 3/2 $GENE $CYTX $CAPN $CYCC $EYES
$$$$$$
28 Feb 15 14:27:17
RT @Wolfofnasdaq: $CYTX Just a few weeks away from the FULLY INITIATED deployment of the U.S. Drug therapy for Scleroderma.
$$$$$$
28 Feb 15 14:27:12
RT @Wolfofnasdaq: $CYTX BTW... This U.S. Drug therapy for Scleroderma is protected from Generic copycat for 10 years...
Erick
28 Feb 15 13:54:15
RT @OzarkTrades: Watchlist for Mon 3/2 $GENE $CYTX $CAPN $CYCC $EYES
Greg David
28 Feb 15 13:53:09
http://t.co/RMvVXnJDpv does trade alerts differently than anyone else. Its super cool. $EJ $EPXY $TRTC $CYTX $BGMD
Phil Goedeker
28 Feb 15 13:47:37
Watchlist for Mon 3/2 $GENE $CYTX $CAPN $CYCC $EYES
James C. Summers
28 Feb 15 12:59:44
@jimicarlos - Correction : $CYTX
Wolf of Wallstreet
28 Feb 15 11:28:43
$CYTX BTW... This U.S. Drug therapy for Scleroderma is protected from Generic copycat for 10 years...
Wolf of Wallstreet
28 Feb 15 11:27:28
$CYTX Just a few weeks away from the FULLY INITIATED deployment of the U.S. Drug therapy for Scleroderma.
HotStockAlert $PKGM$
28 Feb 15 09:35:06
ClayTrader: * * $CYTX Video Chart 02-27-15 * * http://t.co/Gz91CKAdAm
Exposethebest
28 Feb 15 09:35:04
ClayTrader: * * $CYTX Video Chart 02-27-15 * * http://t.co/0hOG7GX01U
DayTraderChoice
28 Feb 15 09:35:02
ClayTrader: * * $CYTX Video Chart 02-27-15 * * http://t.co/ztNq5HL8vN
DayTraderChoice
28 Feb 15 09:34:44
ClayTrader: * * $CYTX Video Chart 02-27-15 * * http://t.co/zo7rAUVfqz
HotStockAlert $PKGM$
28 Feb 15 09:34:42
ClayTrader: * * $CYTX Video Chart 02-27-15 * * http://t.co/0p0auXvxTH
OTPGroupLLC.com
28 Feb 15 09:28:56
http://t.co/vCpf2Iz035 #OTP ClayTrader: * * $CYTX Video Chart 02-27-15 * *: ClayTrader http://t.co/Qhghna7MZm http://t.co/vCpf2Iz035 #OTC
Penny Detective
28 Feb 15 09:28:54
http://t.co/R86fyaXHDZ ClayTrader: * * $CYTX Video Chart 02-27-15 * *: ClayTrader http://t.co/VwNc9BCMHR
OTPGroupLLC.com
28 Feb 15 09:28:25
#OTP http://t.co/vCpf2Iz035 ClayTrader: * * $CYTX Video Chart 02-27-15 * *: ClayTrader http://t.co/FXpf7SwGOF http://t.co/vCpf2Iz035 #IR
moderneconomist.com
28 Feb 15 09:10:43
RT @InvestorsLive: Weekend reading: http://t.co/OUNPauVWgw $BIOC $CYTX $CYCC
Nathan Michaud
28 Feb 15 09:09:38
Weekend reading: http://t.co/OUNPauVWgw $BIOC $CYTX $CYCC
Ale
28 Feb 15 07:54:07
RT @LandonIsrael: @zerosum24 $BSDM, $AAPL off earnings, IMRS this week, $CYTX, $NSPH, $GEVO, currently up in $APPY as well
				
				
By  +Follow August 1, 2013 8:43AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.